Detection of clinically relevant exonic copy-number changes by array CGH

Philip M. Boone, Carlos A. Bacino, Chad A. Shaw, Patricia A. Eng, Patricia M. Hixson, Amber N. Pursley, Sung Hae L Kang, Yaping Yang, Joanna Wiszniewska, Beata A. Nowakowska, Daniela Del Gaudio, Zhilian Xia, Gayle Simpson-Patel, LaDonna L. Immken, James B. Gibson, Anne Tsai, Jennifer A. Bowers, Tyler E. Reimschisel, Christian P. Schaaf, Lorraine Potocki & 14 others Fernando Scaglia, Tomasz Gambin, Maciej Sykulski, Magdalena Bartnik, Katarzyna Derwinska, Barbara Wisniowiecka-Kowalnik, Seema R. Lalani, Frank J. Probst, Weimin Bi, Arthur L. Beaudet, Ankita Patel, James R. Lupski, Sau Wai Cheung, Pawel Stankiewicz

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

Array comparative genomic hybridization (aCGH) is a powerful tool for the molecular elucidation and diagnosis of disorders resulting from genomic copy-number variation (CNV). However, intragenic deletions or duplications-those including genomic intervals of a size smaller than a gene-have remained beyond the detection limit of most clinical aCGH analyses. Increasing array probe number improves genomic resolution, although higher cost may limit implementation, and enhanced detection of benign CNV can confound clinical interpretation. We designed an array with exonic coverage of selected disease and candidate genes and used it clinically to identify losses or gains throughout the genome involving at least one exon and as small as several hundred base pairs in size. In some patients, the detected copy-number change occurs within a gene known to be causative of the observed clinical phenotype, demonstrating the ability of this array to detect clinically relevant CNVs with subkilobase resolution. In summary, we demonstrate the utility of a custom-designed, exon-targeted oligonucleotide array to detect intragenic copy-number changes in patients with various clinical phenotypes.

Original languageEnglish (US)
Pages (from-to)1326-1342
Number of pages17
JournalHuman Mutation
Volume31
Issue number12
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Comparative Genomic Hybridization
Exons
Genes
Phenotype
Oligonucleotide Array Sequence Analysis
Base Pairing
Limit of Detection
Genome
Costs and Cost Analysis

Keywords

  • CGH
  • CNV
  • Comparative genomic hybridization
  • Copy-number variation
  • Exon mutations
  • Intragenic rearrangements

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Boone, P. M., Bacino, C. A., Shaw, C. A., Eng, P. A., Hixson, P. M., Pursley, A. N., ... Stankiewicz, P. (2010). Detection of clinically relevant exonic copy-number changes by array CGH. Human Mutation, 31(12), 1326-1342. https://doi.org/10.1002/humu.21360

Detection of clinically relevant exonic copy-number changes by array CGH. / Boone, Philip M.; Bacino, Carlos A.; Shaw, Chad A.; Eng, Patricia A.; Hixson, Patricia M.; Pursley, Amber N.; Kang, Sung Hae L; Yang, Yaping; Wiszniewska, Joanna; Nowakowska, Beata A.; Del Gaudio, Daniela; Xia, Zhilian; Simpson-Patel, Gayle; Immken, LaDonna L.; Gibson, James B.; Tsai, Anne; Bowers, Jennifer A.; Reimschisel, Tyler E.; Schaaf, Christian P.; Potocki, Lorraine; Scaglia, Fernando; Gambin, Tomasz; Sykulski, Maciej; Bartnik, Magdalena; Derwinska, Katarzyna; Wisniowiecka-Kowalnik, Barbara; Lalani, Seema R.; Probst, Frank J.; Bi, Weimin; Beaudet, Arthur L.; Patel, Ankita; Lupski, James R.; Cheung, Sau Wai; Stankiewicz, Pawel.

In: Human Mutation, Vol. 31, No. 12, 12.2010, p. 1326-1342.

Research output: Contribution to journalArticle

Boone, PM, Bacino, CA, Shaw, CA, Eng, PA, Hixson, PM, Pursley, AN, Kang, SHL, Yang, Y, Wiszniewska, J, Nowakowska, BA, Del Gaudio, D, Xia, Z, Simpson-Patel, G, Immken, LL, Gibson, JB, Tsai, A, Bowers, JA, Reimschisel, TE, Schaaf, CP, Potocki, L, Scaglia, F, Gambin, T, Sykulski, M, Bartnik, M, Derwinska, K, Wisniowiecka-Kowalnik, B, Lalani, SR, Probst, FJ, Bi, W, Beaudet, AL, Patel, A, Lupski, JR, Cheung, SW & Stankiewicz, P 2010, 'Detection of clinically relevant exonic copy-number changes by array CGH', Human Mutation, vol. 31, no. 12, pp. 1326-1342. https://doi.org/10.1002/humu.21360
Boone PM, Bacino CA, Shaw CA, Eng PA, Hixson PM, Pursley AN et al. Detection of clinically relevant exonic copy-number changes by array CGH. Human Mutation. 2010 Dec;31(12):1326-1342. https://doi.org/10.1002/humu.21360
Boone, Philip M. ; Bacino, Carlos A. ; Shaw, Chad A. ; Eng, Patricia A. ; Hixson, Patricia M. ; Pursley, Amber N. ; Kang, Sung Hae L ; Yang, Yaping ; Wiszniewska, Joanna ; Nowakowska, Beata A. ; Del Gaudio, Daniela ; Xia, Zhilian ; Simpson-Patel, Gayle ; Immken, LaDonna L. ; Gibson, James B. ; Tsai, Anne ; Bowers, Jennifer A. ; Reimschisel, Tyler E. ; Schaaf, Christian P. ; Potocki, Lorraine ; Scaglia, Fernando ; Gambin, Tomasz ; Sykulski, Maciej ; Bartnik, Magdalena ; Derwinska, Katarzyna ; Wisniowiecka-Kowalnik, Barbara ; Lalani, Seema R. ; Probst, Frank J. ; Bi, Weimin ; Beaudet, Arthur L. ; Patel, Ankita ; Lupski, James R. ; Cheung, Sau Wai ; Stankiewicz, Pawel. / Detection of clinically relevant exonic copy-number changes by array CGH. In: Human Mutation. 2010 ; Vol. 31, No. 12. pp. 1326-1342.
@article{3676fb02ce844cd0b8debab242156908,
title = "Detection of clinically relevant exonic copy-number changes by array CGH",
abstract = "Array comparative genomic hybridization (aCGH) is a powerful tool for the molecular elucidation and diagnosis of disorders resulting from genomic copy-number variation (CNV). However, intragenic deletions or duplications-those including genomic intervals of a size smaller than a gene-have remained beyond the detection limit of most clinical aCGH analyses. Increasing array probe number improves genomic resolution, although higher cost may limit implementation, and enhanced detection of benign CNV can confound clinical interpretation. We designed an array with exonic coverage of selected disease and candidate genes and used it clinically to identify losses or gains throughout the genome involving at least one exon and as small as several hundred base pairs in size. In some patients, the detected copy-number change occurs within a gene known to be causative of the observed clinical phenotype, demonstrating the ability of this array to detect clinically relevant CNVs with subkilobase resolution. In summary, we demonstrate the utility of a custom-designed, exon-targeted oligonucleotide array to detect intragenic copy-number changes in patients with various clinical phenotypes.",
keywords = "CGH, CNV, Comparative genomic hybridization, Copy-number variation, Exon mutations, Intragenic rearrangements",
author = "Boone, {Philip M.} and Bacino, {Carlos A.} and Shaw, {Chad A.} and Eng, {Patricia A.} and Hixson, {Patricia M.} and Pursley, {Amber N.} and Kang, {Sung Hae L} and Yaping Yang and Joanna Wiszniewska and Nowakowska, {Beata A.} and {Del Gaudio}, Daniela and Zhilian Xia and Gayle Simpson-Patel and Immken, {LaDonna L.} and Gibson, {James B.} and Anne Tsai and Bowers, {Jennifer A.} and Reimschisel, {Tyler E.} and Schaaf, {Christian P.} and Lorraine Potocki and Fernando Scaglia and Tomasz Gambin and Maciej Sykulski and Magdalena Bartnik and Katarzyna Derwinska and Barbara Wisniowiecka-Kowalnik and Lalani, {Seema R.} and Probst, {Frank J.} and Weimin Bi and Beaudet, {Arthur L.} and Ankita Patel and Lupski, {James R.} and Cheung, {Sau Wai} and Pawel Stankiewicz",
year = "2010",
month = "12",
doi = "10.1002/humu.21360",
language = "English (US)",
volume = "31",
pages = "1326--1342",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Detection of clinically relevant exonic copy-number changes by array CGH

AU - Boone, Philip M.

AU - Bacino, Carlos A.

AU - Shaw, Chad A.

AU - Eng, Patricia A.

AU - Hixson, Patricia M.

AU - Pursley, Amber N.

AU - Kang, Sung Hae L

AU - Yang, Yaping

AU - Wiszniewska, Joanna

AU - Nowakowska, Beata A.

AU - Del Gaudio, Daniela

AU - Xia, Zhilian

AU - Simpson-Patel, Gayle

AU - Immken, LaDonna L.

AU - Gibson, James B.

AU - Tsai, Anne

AU - Bowers, Jennifer A.

AU - Reimschisel, Tyler E.

AU - Schaaf, Christian P.

AU - Potocki, Lorraine

AU - Scaglia, Fernando

AU - Gambin, Tomasz

AU - Sykulski, Maciej

AU - Bartnik, Magdalena

AU - Derwinska, Katarzyna

AU - Wisniowiecka-Kowalnik, Barbara

AU - Lalani, Seema R.

AU - Probst, Frank J.

AU - Bi, Weimin

AU - Beaudet, Arthur L.

AU - Patel, Ankita

AU - Lupski, James R.

AU - Cheung, Sau Wai

AU - Stankiewicz, Pawel

PY - 2010/12

Y1 - 2010/12

N2 - Array comparative genomic hybridization (aCGH) is a powerful tool for the molecular elucidation and diagnosis of disorders resulting from genomic copy-number variation (CNV). However, intragenic deletions or duplications-those including genomic intervals of a size smaller than a gene-have remained beyond the detection limit of most clinical aCGH analyses. Increasing array probe number improves genomic resolution, although higher cost may limit implementation, and enhanced detection of benign CNV can confound clinical interpretation. We designed an array with exonic coverage of selected disease and candidate genes and used it clinically to identify losses or gains throughout the genome involving at least one exon and as small as several hundred base pairs in size. In some patients, the detected copy-number change occurs within a gene known to be causative of the observed clinical phenotype, demonstrating the ability of this array to detect clinically relevant CNVs with subkilobase resolution. In summary, we demonstrate the utility of a custom-designed, exon-targeted oligonucleotide array to detect intragenic copy-number changes in patients with various clinical phenotypes.

AB - Array comparative genomic hybridization (aCGH) is a powerful tool for the molecular elucidation and diagnosis of disorders resulting from genomic copy-number variation (CNV). However, intragenic deletions or duplications-those including genomic intervals of a size smaller than a gene-have remained beyond the detection limit of most clinical aCGH analyses. Increasing array probe number improves genomic resolution, although higher cost may limit implementation, and enhanced detection of benign CNV can confound clinical interpretation. We designed an array with exonic coverage of selected disease and candidate genes and used it clinically to identify losses or gains throughout the genome involving at least one exon and as small as several hundred base pairs in size. In some patients, the detected copy-number change occurs within a gene known to be causative of the observed clinical phenotype, demonstrating the ability of this array to detect clinically relevant CNVs with subkilobase resolution. In summary, we demonstrate the utility of a custom-designed, exon-targeted oligonucleotide array to detect intragenic copy-number changes in patients with various clinical phenotypes.

KW - CGH

KW - CNV

KW - Comparative genomic hybridization

KW - Copy-number variation

KW - Exon mutations

KW - Intragenic rearrangements

UR - http://www.scopus.com/inward/record.url?scp=78649559271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649559271&partnerID=8YFLogxK

U2 - 10.1002/humu.21360

DO - 10.1002/humu.21360

M3 - Article

VL - 31

SP - 1326

EP - 1342

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 12

ER -